Howard Schachman

Total Page:16

File Type:pdf, Size:1020Kb

Howard Schachman Howard Schachman University of California Professor of Molecular Biology: Discussions of His Research Over His Scientific Career From the 1940s Until 2010 Interviews conducted by Sondra Schlesinger (2007-2010) Copyright © 2010 by The Regents of the University of California Since 1954 the Regional Oral History Office has been interviewing leading participants in or well-placed witnesses to major events in the development of Northern California, the West, and the nation. Oral History is a method of collecting historical information through tape-recorded interviews between a narrator with firsthand knowledge of historically significant events and a well- informed interviewer, with the goal of preserving substantive additions to the historical record. The tape recording is transcribed, lightly edited for continuity and clarity, and reviewed by the interviewee. The corrected manuscript is bound with photographs and illustrative materials and placed in The Bancroft Library at the University of California, Berkeley, and in other research collections for scholarly use. Because it is primary material, oral history is not intended to present the final, verified, or complete narrative of events. It is a spoken account, offered by the interviewee in response to questioning, and as such it is reflective, partisan, deeply involved, and irreplaceable. ********************************* All uses of this manuscript are covered by a legal agreement between The Regents of the University of California, Howard Schachman, and Sondra Schlesinger, dated November 11, 2010. The manuscript is thereby made available for research purposes. All literary rights in the manuscript, including the right to publish, are reserved to The Bancroft Library of the University of California, Berkeley. Excerpts up to 1000 words from this interview may be quoted for publication without seeking permission as long as the use is non-commercial and properly cited. Requests for permission to quote for publication should be addressed to The Bancroft Library, Head of Public Services, Mail Code 6000, University of California, Berkeley, 94720-6000, and should follow instructions available online at http://bancroft.berkeley.edu/ROHO/collections/cite.html It is recommended that this oral history be cited as follows: Howard Schachman, “University of California Professor of Molecular Biology: Discussions of His Research Over His Scientific Career From the 1940s Until 2010,” conducted by Sondra Schlesinger between 2007 and 2010, Regional Oral History Office, The Bancroft Library, University of California, Berkeley, 2010. Howard at the ultracentrifuge in 1966 iv Table of Contents–Howard Schachman Introduction vi Acknowledgement vii Audio File 1 Oct 18 and 22, 2007, January 16, 2008 1 Howard’s move from engineering to biology–how he was hired as a technician to work for Max Lauffer at the Rockefeller Institute for Medical Research, Princeton, New Jersey–use of the Sharples centrifuge for purifying tobacco mosaic virus (TMV)–graduate school at Harvard but getting his PhD at Princeton–the navy–move to the University of California, Berkeley with Wendell Stanley(1948)– initial studies with TMV and the use of the ultracentrifuge– measuring the compressibility of particles–synthetic boundary cells–Ed Pickels and Spinco, work on rabbit papilloma virus–Robley Williams, TMV and the electron microscope. Audio File 2 January 21, 2008 29 Homogeneity of TMV–discovery of ribosomes in E. coli–discovery of chromatophores in Rhodospirillum rubrum–research on DNA and development of ultraviolet absorption optics for the ultracentrifuge with Spinco–development of a photoelectric absorption scanning apparatus and a double beam instrument at Berkeley–a Rayleigh interferometer with Ed Pickels–initial work with Arthur Kornberg to show by sedimentation that DNA was synthesized in vitro–suggests to Matt Meselson the use of cesium chloride for the Meselson-Stahl experiment that showed that DNA replicates by a semi-conservative mechanism. v Reflections on research and collaborations with the ultracentrifuge 48 Audio File 3 January 22, 2008 49 Sabbatical with Arthur Kornberg in St. Louis–summer at Woods Hole –discovery of copolymer of deoxyadenylate-thymidylate in alternating sequence–discussions about Kornberg’s lab and Washington University –Howard’s humorous talk called “Money Transferase” at the Gordon Conference–Aspartic transcarbamylase (ATCase) and collaboration with John Gerhardt–catalytic and regulatory subunits of the enzyme. Audio File 4 March 17 and 19, 2008 66 Thoughts about Ann Forman, a student in Howard’s lab–agreement among those working on ATCase that the catalytic chains were organized as two trimers and the regulatory chains were organized as three dimers–study of hybrid subunits of aldolase to show protein is a tetramer–studies with hybrids of catalytic subunits of ATCase to show protein is a trimer–cross-linked regulatory dimers reassociate with catalytic trimers indicating that dimers must exist endogenously– George Stark and binding studies with N-(phosphonacetyl)-l-aspartate (PALA) a bi-substrate analog–ATCase can exist as two trimers and two regulatory dimers but is less stable–ATCase contains zinc– assembly mechanisms–beginning of genetic experiments–pyrB, the gene that codes for catalytic trimers, previously identified– Schachman laboratory identifies pyrI gene by sequencing–pyrB and pyrI are an operon–site-directed mutagenesis experiments begin in the lab–Howard talks about his role in getting coordinates of X-ray structures deposited in the Brookhaven Bank. Audio File 5 August 20 and 22, 2008 88 Summary of ATCase trimers and dimers and discussion about oligomers–site-directed mutagenesis and hybridization of subunits– further discussion of monkey models and why trimers are more stable than dimers–discussion of assembly mechanism–reflections comparing the significance of the discovery of ribosomes and the satisfaction derived from his studies proving the compressibility of particles in the ultracentrifuge–discussion of conformational states of ATCase on binding of ligands–studies of assembly of ATCase in vivo in E. coli–ATCase and allosteric interactions–discussion of the Monod, Wyman, Changeux model of conformational changes in enzymes on interacting with substrates or inhibitors–allostery and global conformational changes of ATCase using radioactive PALA (N-(phosphonacetyl)-L-aspartate)–ligand-promoted conformational changes–reversibility of ATCase and story about Jeff Foote. Audio File 6 January 23, 2009 111 Dissociation and reassociation of catalytic trimers–crystallographic vi studies showed that the individual catalytic chains in ATCase are folded into two clearly identifiable domains–genetic engineering to study the catalytic chain, separating the polypeptide into two fragments –experiments showing that two separated fragments assemble in the test tube and in E. coli–genetic engineering experiments to introduce new N- and C- termini in the polypeptide chain. Audio File 7 March 8, 2010 122 Collaboration with Tom Alper on x-ray studies of the catalytic subunit of ATCase–genetic engineering to study the regulatory subunit–a seventy amino acid peptide of the regulatory subunit binds to the catalytic trimer affecting the activity–collaboration with Lewis Kay in Toronto on NMR studies of ATCase–further x-ray studies with Howard’s last postdoctoral student and Tom Alper. Audio File 8 July 19, 2010 131 Awards Howard has received–President of ASBMB and FASEB–meetings with lawyers about fraud versus misconduct in science–Howard proposes fabrication, falsification, and plagiarism as definition of misconduct–Howard serves as an ombudsman for Harold Varmus when Harold heads the NIH–AAAS awards Howard the Scientific Freedom and Responsibility Award–ASBMB establishes the Howard K. Schachman Public Service Award. Vita 144 List of Publications 146 Sondra Schlesinger biosketch 166 Illustrations “Money Transferase” at the Gordon Conference 61 Another of Howard’s humorous slides 61 Monkey model showing one catalytic trimer and one 71 regulatory dimer Monkey model showing three regulatory dimers and one trimer 72 10 steps of reversible and non-reversible steps in assembly 80 Hybridization scheme to demonstrate shared active sites 92 Scheme for the assembly of ATCase from subunits 95 Ribbon diagram of single chain of catalytic subunit of ATCase 113 Another ribbon diagram with numbered amino acids 119 Diagram showing circularly permuted catalytic chains of ATCase 121 vii INTRODUCTION by Sondra Schlesinger Howard’s career at the University of California has spanned over 60 years––a period that has seen many changes in the world and also in Howard’s field of biochemistry. The field of molecular biology did not even exist when Howard arrived at Berkeley. In 1948, the year that Howard joined the faculty at Berkeley, biologists had not yet recognized that DNA was the genetic material. O. T. Avery, C. M. McLeod and M. McCarthy published their landmark discovery in 1944 showing that it was DNA, not protein, that was responsible for bacterial transformation. Those results did not convince everyone and the oft-cited Hershey-Chase experiment showing that only the DNA of the bacteriophage need enter the bacterial cell for phage replication was not published until 1952. In the early 1940s, although most scientists agreed that proteins consisted of amino acids linked together in a linear array, how they were synthesized and their three- dimensional complexities were unimagined. The Bancroft Library at the
Recommended publications
  • 2008-Annual-Report.Pdf
    whitehead institute 2008 AnnuAl RepoRt. a year in the life of a scientific community empowered to explore biology’s most fundamental questions for the betterment of human health. whitehead institute 2008 annual report a Preserving the mission, contents facing the future 1 preserving the mission, it’s customary in this space to recount and reflect facing the future on the accomplishments of the year gone by. i’ll certainly do so here—proudly—but in many 5 scientific achievement important ways, 2008 was about positioning the institute for years to come. 15 principal investigators many colleges, universities, and independent 30 whitehead fellows research institutions found themselves in dire fiscal positions at the close of 2008 and entered 34 community evolution 2009 in operational crisis reflective of the global economic environment. hiring freezes and large- 40 honor roll of donors scale workforce reductions have become the norm. although whitehead institute is certainly not 46 financial summary insulated from the impact of the downturn, i am 48 leadership pleased and somewhat humbled to report that the institute remains financially strong and no less 49 sited for science committed to scientific excellence. david page, director over the past two years, we have been engaged in a focused effort to increase efficiency and editor & direCtor reduce our administrative costs, with the explicit goal of ensuring that as much of the institute’s matt fearer revenue as possible directly supports Whitehead research. Our approach, which has resulted in assoCiate editor nicole giese a 10-percent reduction in operational expense, has been carefully considered. every decision offiCe of CommuniCation and PubliC affairs has been evaluated not just for its potential effects on our scientific mission, but also for 617.258.5183 www.whitehead.mit.edu possible consequences to the whitehead community and its unique culture.
    [Show full text]
  • Medical Advisory Board September 1, 2006–August 31, 2007
    hoWard hughes medical iNstitute 2007 annual report What’s Next h o W ard hughes medical i 4000 oNes Bridge road chevy chase, marylaNd 20815-6789 www.hhmi.org N stitute 2007 a nn ual report What’s Next Letter from the president 2 The primary purpose and objective of the conversation: wiLLiam r. Lummis 6 Howard Hughes Medical Institute shall be the promotion of human knowledge within the CREDITS thiNkiNg field of the basic sciences (principally the field of like medical research and education) and the a scieNtist 8 effective application thereof for the benefit of mankind. Page 1 Page 25 Page 43 Page 50 seeiNg Illustration by Riccardo Vecchio Südhof: Paul Fetters; Fuchs: Janelia Farm lab: © Photography Neurotoxin (Brunger & Chapman): Page 3 Matthew Septimus; SCNT images: by Brad Feinknopf; First level of Rongsheng Jin and Axel Brunger; iN Bruce Weller Blake Porch and Chris Vargas/HHMI lab building: © Photography by Shadlen: Paul Fetters; Mouse Page 6 Page 26 Brad Feinknopf (Tsai): Li-Huei Tsai; Zoghbi: Agapito NeW Illustration by Riccardo Vecchio Arabidopsis: Laboratory of Joanne Page 44 Sanchez/Baylor College 14 Page 8 Chory; Chory: Courtesy of Salk Janelia Farm guest housing: © Jeff Page 51 Ways Illustration by Riccardo Vecchio Institute Goldberg/Esto; Dudman: Matthew Szostak: Mark Wilson; Evans: Fred Page 10 Page 27 Septimus; Lee: Oliver Wien; Greaves/PR Newswire, © HHMI; Mello: Erika Larsen; Hannon: Zack Rosenthal: Paul Fetters; Students: Leonardo: Paul Fetters; Riddiford: Steitz: Harold Shapiro; Lefkowitz: capacity Seckler/AP, © HHMI; Lowe: Zack Paul Fetters; Map: Reprinted by Paul Fetters; Truman: Paul Fetters Stewart Waller/PR Newswire, Seckler/AP, © HHMI permission from Macmillan Page 46 © HHMI for Page 12 Publishers, Ltd.: Nature vol.
    [Show full text]
  • Structure & Symmetry
    HAPPY HOLIDAYS ASBMB MEMBERS December 2008 Structure & Symmetry American Society for Biochemistry and Molecular Biology J\\PfliGifk\`ej n`k_*.#'''>=G$kX^^\[FI=Zcfe\j 8 $@C- 9 "@C- : ; >=G$kX^^\[Kil\FI=Zcfe\jXi\kiXej]\Zk\[`ekf?<B)0* Z\ccjXe[k_\kX^^\[gifk\`ejXi\m`jlXc`q\[[li`e^@C$- `e[lZ\[elZc\XikiXejcfZXk`feJK8K*#gXe\c8Xe[9 Xe[`e Ôcfgf[`XXe[jki\jjÔY\i]fidXk`fe8Zk`e#gXe\c:Xe[; % Kil\FI= Fi`>\e\jXclk\j >\efd\n`[\FI=Zcfe\j k_\>=Gg`fe\\ij ]fik_\`iEfY\c ]fikX^^\[gifk\`e\ogi\jj`fe Gi`q\XnXi[ ×:$k\id`eXckX^f]>=G ×J\hl\eZ\m\i`Ô\[Xe[^lXiXek\\[ ×<Xj`cpj_lkkc\[`ekf)'[\jk`eXk`fem\Zkfij ×KiXej]\Zk`fe$i\X[p1('l^gcXjd`[;E8 fi`^\e\%Zfd&fi] ORG-041-GFPTaggedAd_ASBMB_v7.indd 1 10/20/08 12:29:39 PM contents DECEMBER 2008 ON THE COVER: Captivated by the symmetry society news of molecular structure, Sung-Hou Kim has been a 2 From the Editor leader in revealing symmetry 3 President’s Message through his studies in crystallography and 5 Letters to the Editor structural genomics. 30 6 Washington Update 12 Retrospective: Anthony G. San Pietro FASEB releases new Breakthroughs in special interest Bioscience. 6 13 Science’s Role in Foreign Policy 14 ASBMB Round Table: Jim Wells and Mary Woolley 16 Keeping Women in Science 19 Grammar and Writing Tips 2009 meeting 20 The 2009 Fritz Lipmann Lectureship: Douglas C. Rees 21 The 2009 ASBMB Merck Award: John Kuriyan 22 The 2009 FASEB Excellence in Science Award: Susan Lindquist science focus 30 Sung-Hou Kim: Consummate Crystallographer departments 7 News from the Hill 10 Member Spotlight 23 Education and Training A leaky pipeline for women scientists.
    [Show full text]
  • SCIENCE HISTORY INSTITUTE ISABELLA KARLE and JEROME
    SCIENCE HISTORY INSTITUTE ISABELLA KARLE and JEROME KARLE Transcript of an Interview Conducted by James J. Bohning and David K. Van Keuren at Naval Research Laboratory Washington, District of Columbia on 26 February, 15 June and 9 September 1987 (With Subsequent Corrections and Additions) Upon Isabella Karle’s death in 2017, this oral history was designated Free Access. Please note: This oral history is protected by U.S. copyright law and shall not be reproduced or disseminated in any way without the express permission of the Science History Institute. Users citing this interview for purposes of publication are obliged under the terms of the Center for Oral History, Science History Institute, to credit the Science History Institute using the format below: Isabella Karle and Jerome Karle, interview by James J. Bohning and David K. Van Keuren at Naval Research Laboratory, Washington, District of Columbia, 26 February, 15 June and 9 September 1987 (Philadelphia: Science History Institute, Oral History Transcript # 0066). Formed by the merger of the Chemical Heritage Foundation and the Life Sciences Foundation, the Science History Institute collects and shares the stories of innovators and of discoveries that shape our lives. We preserve and interpret the history of chemistry, chemical engineering, and the life sciences. Headquartered in Philadelphia, with offices in California and Europe, the Institute houses an archive and a library for historians and researchers, a fellowship program for visiting scholars from around the globe, a community of researchers who examine historical and contemporary issues, and an acclaimed museum that is free and open to the public. For more information visit sciencehistory.org.
    [Show full text]
  • Division of Extramural Activities Annual Report 2002
    Division of Extramural Activities Annual Report 2002 National Institutes of Health National Cancer Institute Molecular Diagnosis of Cancer Gene expression profiling using DNA microarrays is a technology that arose as a consequence of the Human Genome Project. With DNA microarrays, it is possible to determine the activity (“expression”) of tens of thousands of genes in parallel on microarray plates. The expression of genes influences the biological behavior of a cell because it dictates which proteins the cell can make and gives cells their unique characteristics. In the DNA microarray images shown at the bottom of the cover illustration, each spot represents a different human gene. Red, yellow, and green spots indicate that a gene is expressed at high, intermediate, and low levels, respectively. The pattern of expression of all of the genes in a cell constitutes its gene expression “profile.” Using DNA microarrays, different types of normal and malignant cells can be distinguished from one another because they have distinct gene expression profiles. Shown at the top of the cover illustration are photomicrographs of lymph node biopsies from two patients with diffuse large B cell lymphoma. The tumor at the right belongs to the germinal center B cell-like subgroup of diffuse large B cell lymphoma. Patients with this lymphoma type have a relatively favorable 5-year survival rate of 59% following multi-agent chemotherapy. The tumor at the left belongs to the activated B cell-like subgroup of diffuse large B cell lymphoma. Patients with this lymphoma type have a less favorable 5-year survival rate of 31%. Although the tumors from these patients were indistinguishable histologically, they had striking differences in their gene expression profiles, as exemplified by the microarray images shown below each lymphoma subgroup.
    [Show full text]
  • NIH Conflict of Interest Regs Revised
    OCTOBEROCTOBER 2005 www.asbmb.org Constituent Society of FASEB AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY NIH Conflict of Interest Regs Revised SEE PAGE 30 FOR NEW CLARA BENSON TRAVEL FELLOWSHIP AWARD Held in conjunction with EB2006 Custom Antibodies Your Way! Choose the protocol that is right for you! QwikScreen ™: 65 day, 2 rabbit protocol - 4 immunizations, 3 bleeds/rabbit (~100ml serum), customer supplied peptide/protein - Options: Peptide synthesis, immunograde Conjugation to carrier u ELISA u u Animal extensionsMS analysis $685 Standard: 80 day, 2 rabbit protocol - 5 immunizations, 5 bleeds/rabbit (~ 200ml ser Options: um), ELISA, customer supplied peptide/pr Peptide synthesis MS Check™ peptide sequence confirmation u HPLC purified peptide Affinity purification otein - Pinnacle: $975 u HPLC and MS analysis u Complete Affinity Purified Protocol- Animal extensions 2 rabbit pr 5 bleeds/rabbitotocol, (~ 200mlepitope serum), design, peptide PhD technical synthesis support, (up to 20mer),5 immunizations, HPLC purified to ~85%, 5+mg peptide to customer, ELISA, evaluation period, affinity purification, and morMS Check™ peptide sequence confirmationNo Hidden Charges! e… - Discounts for Multiple Protocols$1795 , Includes peptide sequencing by CID MS/MS– u Guaranteed Peptide Let our enthusiasm for scienceExpert workTechnical for SupportFidelity! P: 508.303.8222 www.21stcenturybio.com Toll-free: 877.217.8238 F: 508.303.8333 you! E: [email protected] www.asbmb.org AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY OCTOBER
    [Show full text]
  • Commencement Friday, June 1, 2018
    THE CITY COLLEGE OF NEW YORK COMMENCEMENT FRIDAY, JUNE 1, 2018 THE CITY UNIVERSITY OF NEW YORK Commencement Friday, June 1, 2018, 9:30 a.m. South Campus Great Lawn Presiding Vince Boudreau President, The City College of New York Academic Procession Interim Provost Tony Liss Taimoor Arif President, Undergraduate Student Government Cyrille Njikeng Executive Chair, Graduate Student Council Associate Dean Ardie Walser The Grove School of Engineering Ph.D Graduates Interim Dean Kevin Foster Colin Powell School for Civic and Global Leadership Faria Tasnim and Tyler Walls Dean Erec Koch The Division of Humanities and the Arts Sophie Ziner and Lucius Seo Dean Maurizio Trevisan The Sophie Davis Program in Biomedical Education in the CUNY School of Medicine Samantha Lau and Gabriella Schmuter Acting Dean V. Parameswaran Nair The Division of Science Lisa Lopez and Lucy Lopez Acting Dean Gordon Gebert The Bernard and Anne Spitzer School of Architecture Jun Nam and Gabriel Morales Director Hillary Brown Sustainability in the Urban Environment Michael Duffy, Evelyn Levine and Robin Perl Dean Mary Erina Driscoll The School of Education Massiel A. De León de la Serna and Samson Baker Dean Juan Carlos Mercado The Division of Interdisciplinary Studies at the Center for Worker Education Gabrielle Gallo and Jose Miranda Dean Gilda Barabino The Grove School of Engineering Vivakeanand “Vishal” Boodhan and Joseph Rettberg Academic Procession Faculty (continued) Reunion Classes 1978, 1968, 1958 and 1948 President’s Platform Party Deans and Vice Presidents of the College Student Government Leaders Valedictorian Salutatorian Honored Guests Interim Provost Tony Liss Chief Marshal Janet Steele President Vince Boudreau The Color Guard of the CUNY Army ROTC Program presents the National Colors The National Anthem Megumi Toyama BFA in Jazz Vocal Studies Greetings Fernando Ferrer The Board of Trustees The City University of New York Chancellor James B.
    [Show full text]
  • INCITE IR FINAL 7-19-11.Pdf
    Contents 3 INCITE Accelerates Research Breakthroughs PRODUCTION TEAM with Leadership Computing Team Leader: Julia C. White 5 Modeling Turbulent Combustion Speeds Design of Power and Propulsion Devices Publication Director: Dawn Levy 7 Advanced Computing Aids Design Editors: Priscilla Henson, Dawn Levy of Next-Generation Nuclear Reactors Contributing Science Writers: Cheryl 9 Breakthrough Fusion Simulations Drugan, Eric Gedenk, Kathryn Jandeska, Shed Light on Plasma Confinement Scott Jones, Dawn Levy, Caitlin Rockett, Leo Williams, Laura Wolf 11 Chemistry and Materials Computations Speed Clean Energy Production and Storage Graphic Designer: Jason Smith 13 Jaguar Supercomputer Performs Reviewers: Arthur Bland, Susan Coghlan, Most Advanced Earthquake Simulation James J. Hack, Bronson Messer, Paul Messina, Michael Papka, Katherine Riley, 15 Leadership Computing Enables New Insights Julia C. White into the Flow Properties of Concrete Advisors: Ashley Barker, Jayson Hines, 17 Elucidation of Stress Corrosion David Martin Cracking Mechanisms 19 High-Performance Computing Provides CONTACT First Simulation of Abrupt Climate Change Julia C. White INCITE Manager 21 Supercomputers Predict the Structures Phone: 865-241-8796 of Large Proteins Key in Health [email protected] 23 Simulations Spur Scientists to Revise Theory of How Stars Explode and a Pulsar Gets Its Spin 25 Scientists Model the Molecular Basis of Parkinson’s Disease The research described herein was made possible through awards of computer time 27 Unprecedented Simulation Lessens the Risk provided through the Innovative and Novel Computational Impact on Theory and of Combustion Instabilities in Turbines Experiment (INCITE) program. The research used either resources of the Oak Ridge Leadership Computing Facility, located in the National Center for Computational Sciences at Oak Ridge National Laboratory and supported by the Office of Science of the U.S.
    [Show full text]
  • NAM Annual Report 2019
    2019 Annual Report CONTENTS Special Insert: Responding to the COVID-19 Pandemic 3 Letter from the President 5 2019–2020 Governing Council 7 Organizational Chart 8 The IOM/NAM 50th Anniversary Celebration 9 Program Highlights 10 Responding to Critical & Pressing Issues Confronting the U.S. Opioid Epidemic, 11 Promoting Clinician Well-Being & Resilience, 13 Human Germline Genome Editing, 15 Climate Change & Human Health, 16 Advising the Nation & the World on Health & Health Care Advancing Health Equity, 17 Artificial Intelligence in Health Care, 19 Understanding Heterogeneous Treatment Effects, 20 Vital Directions in Health & Health Care, 21 The Future of Nursing, 22 Leading & Inspiring for the Future Healthy Longevity Global Grand Challenge, 23 Committee on Emerging Science, Technology, & Innovation, 25 Member Highlights 26 Inaugural Election of NAM Officers, 27 Members Inducted in 2019 (Class of 2018), 28 Members Elected in 2019 (Class of 2019), 30 2019 Nobel Laureates, 33 2019 Annual Meeting, 34 In Memoriam, 36 Fellowships & Leadership Programs 37 Awards 42 Finances 47 Donor Appreciation 48 Contact Us 65 2 SPECIAL INSERT Responding to the COVID-19 Pandemic As this document entered its final stages of production, coronavirus disease (COVID-19) began to spread around the world—quickly becoming the most destructive pandemic in a century. The National Academy of Medicine quickly initiated a short-term reorientation of its existing programs to respond to the diverse and far-reaching health impacts of the pandemic, including in the areas of equity, workforce, aging, vulnerable populations, health system strengthening, and scientific and technological innovation. An “impact map” that guides the NAM’s role and priorities with regard to the COVID-19 response appears below.
    [Show full text]
  • Randy Schekman Dept of Molecular and Cell Biology Howard Hughes Medical Institute University of California, Berkeley • Subscription, Open Access Or Hybrid
    Randy Schekman Dept of Molecular and Cell Biology Howard Hughes Medical Institute University of California, Berkeley • Subscription, open access or hybrid • Print format with online access or online only • Private commercial, public profit-generating or not-for-profit • Professional editors, academic editors or both • Support in Europe – European Commission makes OA a “general principle” of Horizon 2020 - €80billion programme in research and innovation. – “We need Open Access to scientific information” (Neelie Kroes, Vice-President of the European Commission responsible for the Digital Agenda” • Support in the US – Research Works Act - withdrawn – Petition calling for OA received over 29k signatures – Federal Research Public Access Act reintroduced Publications BMC PLoS Hindawi %PubMed available as open access in PMC Number of WT, and HHMI papers published in Nature, Science, Cell and PLoS Bio/Med/Gen in 2011 and available through PubMed Central [Data collected: Nov 2011] 140 120 100 Total number of articles published in 2011, attributed to WT or HHMI 80 Total number of articles published in 2011, attributed to WT or HHMI, and in PMC 60 40 20 0 Nature Science Cell PLoS Biol/Med/Gen How does peer review work? The goals of peer review • Assess technical merits of Open access is just work • Assess likely significance one part of a of work broader transition http://www.scienceforseo.com/wp-content/uploads/2009/04/peerreview.jpg Is peer review The goals of peer broken? review Open access is just one part of a broader transition http://the-political-ear.com/?p=595
    [Show full text]
  • Biomolecular Modeling Thrives in the Age of Technology
    PERSPECTIVE https://doi.org/10.1038/s43588-021-00060-9 Biomolecular modeling thrives in the age of technology Tamar Schlick 1,2,3 ✉ and Stephanie Portillo-Ledesma1 The biomolecular modeling field has flourished since its early days in the 1970s due to the rapid adaptation and tailoring of state-of-the-art technology. The resulting dramatic increase in size and timespan of biomolecular simulations has outpaced Moore’s law. Here, we discuss the role of knowledge-based versus physics-based methods and hardware versus software advances in propelling the field forward. This rapid adaptation and outreach suggests a bright future for modeling, where the- ory, experimentation and simulation define three pillars needed to address future scientific and biomedical challenges. he trajectory of the field of biomolecular modeling and Problems range from unraveling the folding pathways of proteins simulation is a classic example of success driven by an and identification of new therapeutic targets for common human Teclectic mixture of ideas, people, technology and serendip- diseases to the design of novel materials and pharmaceuticals. With ity. From the early days of simulations and force-field develop- the recent emergence of the coronavirus pandemic, all these tools ment through pioneering applications to structure determination, are being utilized in numerous community efforts for simulating enzyme kinetics and molecular dynamics simulations, the field COVID-19 related systems. Similar to the exponential growth so has gone through notable highs and lows1 (Fig. 1). The 1980s were familiar to us now in connection with the spread of COVID-19 marked by advances made possible by supercomputers2,3, and, at infections, exponential progress is only realized when we take stock the same time, by deflated high expectations when it was realized of long timeframes.
    [Show full text]
  • Harry S Truman
    THE MALEVOLENT PRESIDENT HARRY S TRUMAN Harry S Truman has been referred to as “little” but he was not at all short. He has been referred to as “limited” and as “ignorant” although these descriptors do not accurately capture his actual conduct. The key to understanding his character and his conduct, and the key to understanding why it is that he has been referred to as “little,” is to grasp that here we had an utterly malevolent man — someone who took the greatest of delight in the doing of harm to those of whose existence he disapproved, and in general to anyone who sought in any way to oppose his desires. He said to his biographer, David McCullough, “I never gave anybody hell, I just told the truth and they thought it was hell,” and the historian repeated this saying on page 664 in his 2003 Pulitzer-Prize-winning biography TRUMAN exactly as if the making of such an assertion meant that that assertion needed to be the truth. However, when Truman said that to his biographer, he was merely lying — lying again. All he ever knew to do was give people hell, and lie. In fact we can safely assert that this man’s life –like that “S” middle initial– stood for nothing at all. THE PRESIDENTIAL PAPERS “NARRATIVE HISTORY” AMOUNTS TO FABULATION, THE REAL STUFF BEING MERE CHRONOLOGY “Stack of the Artist of Kouroo” Project Harry S Truman HDT WHAT? INDEX HARRY S TRUMAN PRESIDENT HARRY S TRUMAN Table of Altitudes Yoda 2 ' 0 '' Lavinia Warren 2 ' 8 '' Tom Thumb, Jr.
    [Show full text]